Hypoxia up-regulates the effects of prostaglandin E 2 on tumor angiogenesis in ovarian cancer cells

Genhai Zhu, Ghassan M. Saed, Gunter Deppe, Michael Peter Diamond, Adnan R. Munkarah

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Objective. Emerging evidence supports a role for prostaglandins (PG) and their synthesizing enzyme, cyclooxygenase (COX), in tumor angiogenesis. The objective of this study was to investigate the effects of prostaglandin E 2 (PGE 2) on the expression of vascular endothelial growth factor (VEGF) and hypoxia-inducible transcription factor-1 alpha (HIF-1α) genes in epithelial ovarian cancer (EOC) cells. Methods. Two human EOC cell lines, MDAH-2774 and SKOV-3, were treated with exogenous dimethyl prostaglandin E 2 (dmPGE 2) at two doses of 10 and 50 μg/ml and cultured for 24 h under both normoxic and hypoxic conditions. Total RNA was extracted from EOC cells with the use of a monophasic solution of phenol and GITC/Trizol method. The levels of COX-2, VEGF, and HIF-1α mRNA were measured by quantitative reverse transcription PCR (RT-PCR). Results. Under normoxic conditions, treatment of both ovarian cancer cell lines with dmPGE 2 resulted in a significant increase in VEGF expression but had no effect on HIF-1α. Culturing the cells under hypoxic conditions resulted in an increase in HIF-1α and VEGF mRNAs. The combination of hypoxia and dmPGE 2 treatment resulted in the highest levels of VEGF and HIF-1α when compared to either individual treatment. Conclusion. PGE 2 is a potent stimulator of VEGF expression in ovarian cancer cells. This effect of PG is further potentiated under hypoxic conditions where it is also associated with a significant increase in HIF-1α expression.

Original languageEnglish (US)
Pages (from-to)422-426
Number of pages5
JournalGynecologic Oncology
Volume94
Issue number2
DOIs
StatePublished - Aug 1 2004
Externally publishedYes

Fingerprint

Hypoxia-Inducible Factor 1
Prostaglandins E
Ovarian Neoplasms
Vascular Endothelial Growth Factor A
Transcription Factors
Up-Regulation
Neoplasms
Prostaglandins
Cell Line
Messenger RNA
Cyclooxygenase 2
Prostaglandin-Endoperoxide Synthases
Phenol
Reverse Transcription
Hypoxia
RNA
Polymerase Chain Reaction
Enzymes
Genes
Ovarian epithelial cancer

Keywords

  • Angiogenesis
  • Hypoxia
  • Ovarian cancer
  • Prostaglandin

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Hypoxia up-regulates the effects of prostaglandin E 2 on tumor angiogenesis in ovarian cancer cells. / Zhu, Genhai; Saed, Ghassan M.; Deppe, Gunter; Diamond, Michael Peter; Munkarah, Adnan R.

In: Gynecologic Oncology, Vol. 94, No. 2, 01.08.2004, p. 422-426.

Research output: Contribution to journalArticle

Zhu, Genhai ; Saed, Ghassan M. ; Deppe, Gunter ; Diamond, Michael Peter ; Munkarah, Adnan R. / Hypoxia up-regulates the effects of prostaglandin E 2 on tumor angiogenesis in ovarian cancer cells. In: Gynecologic Oncology. 2004 ; Vol. 94, No. 2. pp. 422-426.
@article{0c3d3ab22dda4ebca2bcbdf354599863,
title = "Hypoxia up-regulates the effects of prostaglandin E 2 on tumor angiogenesis in ovarian cancer cells",
abstract = "Objective. Emerging evidence supports a role for prostaglandins (PG) and their synthesizing enzyme, cyclooxygenase (COX), in tumor angiogenesis. The objective of this study was to investigate the effects of prostaglandin E 2 (PGE 2) on the expression of vascular endothelial growth factor (VEGF) and hypoxia-inducible transcription factor-1 alpha (HIF-1α) genes in epithelial ovarian cancer (EOC) cells. Methods. Two human EOC cell lines, MDAH-2774 and SKOV-3, were treated with exogenous dimethyl prostaglandin E 2 (dmPGE 2) at two doses of 10 and 50 μg/ml and cultured for 24 h under both normoxic and hypoxic conditions. Total RNA was extracted from EOC cells with the use of a monophasic solution of phenol and GITC/Trizol method. The levels of COX-2, VEGF, and HIF-1α mRNA were measured by quantitative reverse transcription PCR (RT-PCR). Results. Under normoxic conditions, treatment of both ovarian cancer cell lines with dmPGE 2 resulted in a significant increase in VEGF expression but had no effect on HIF-1α. Culturing the cells under hypoxic conditions resulted in an increase in HIF-1α and VEGF mRNAs. The combination of hypoxia and dmPGE 2 treatment resulted in the highest levels of VEGF and HIF-1α when compared to either individual treatment. Conclusion. PGE 2 is a potent stimulator of VEGF expression in ovarian cancer cells. This effect of PG is further potentiated under hypoxic conditions where it is also associated with a significant increase in HIF-1α expression.",
keywords = "Angiogenesis, Hypoxia, Ovarian cancer, Prostaglandin",
author = "Genhai Zhu and Saed, {Ghassan M.} and Gunter Deppe and Diamond, {Michael Peter} and Munkarah, {Adnan R.}",
year = "2004",
month = "8",
day = "1",
doi = "10.1016/j.ygyno.2004.05.010",
language = "English (US)",
volume = "94",
pages = "422--426",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Hypoxia up-regulates the effects of prostaglandin E 2 on tumor angiogenesis in ovarian cancer cells

AU - Zhu, Genhai

AU - Saed, Ghassan M.

AU - Deppe, Gunter

AU - Diamond, Michael Peter

AU - Munkarah, Adnan R.

PY - 2004/8/1

Y1 - 2004/8/1

N2 - Objective. Emerging evidence supports a role for prostaglandins (PG) and their synthesizing enzyme, cyclooxygenase (COX), in tumor angiogenesis. The objective of this study was to investigate the effects of prostaglandin E 2 (PGE 2) on the expression of vascular endothelial growth factor (VEGF) and hypoxia-inducible transcription factor-1 alpha (HIF-1α) genes in epithelial ovarian cancer (EOC) cells. Methods. Two human EOC cell lines, MDAH-2774 and SKOV-3, were treated with exogenous dimethyl prostaglandin E 2 (dmPGE 2) at two doses of 10 and 50 μg/ml and cultured for 24 h under both normoxic and hypoxic conditions. Total RNA was extracted from EOC cells with the use of a monophasic solution of phenol and GITC/Trizol method. The levels of COX-2, VEGF, and HIF-1α mRNA were measured by quantitative reverse transcription PCR (RT-PCR). Results. Under normoxic conditions, treatment of both ovarian cancer cell lines with dmPGE 2 resulted in a significant increase in VEGF expression but had no effect on HIF-1α. Culturing the cells under hypoxic conditions resulted in an increase in HIF-1α and VEGF mRNAs. The combination of hypoxia and dmPGE 2 treatment resulted in the highest levels of VEGF and HIF-1α when compared to either individual treatment. Conclusion. PGE 2 is a potent stimulator of VEGF expression in ovarian cancer cells. This effect of PG is further potentiated under hypoxic conditions where it is also associated with a significant increase in HIF-1α expression.

AB - Objective. Emerging evidence supports a role for prostaglandins (PG) and their synthesizing enzyme, cyclooxygenase (COX), in tumor angiogenesis. The objective of this study was to investigate the effects of prostaglandin E 2 (PGE 2) on the expression of vascular endothelial growth factor (VEGF) and hypoxia-inducible transcription factor-1 alpha (HIF-1α) genes in epithelial ovarian cancer (EOC) cells. Methods. Two human EOC cell lines, MDAH-2774 and SKOV-3, were treated with exogenous dimethyl prostaglandin E 2 (dmPGE 2) at two doses of 10 and 50 μg/ml and cultured for 24 h under both normoxic and hypoxic conditions. Total RNA was extracted from EOC cells with the use of a monophasic solution of phenol and GITC/Trizol method. The levels of COX-2, VEGF, and HIF-1α mRNA were measured by quantitative reverse transcription PCR (RT-PCR). Results. Under normoxic conditions, treatment of both ovarian cancer cell lines with dmPGE 2 resulted in a significant increase in VEGF expression but had no effect on HIF-1α. Culturing the cells under hypoxic conditions resulted in an increase in HIF-1α and VEGF mRNAs. The combination of hypoxia and dmPGE 2 treatment resulted in the highest levels of VEGF and HIF-1α when compared to either individual treatment. Conclusion. PGE 2 is a potent stimulator of VEGF expression in ovarian cancer cells. This effect of PG is further potentiated under hypoxic conditions where it is also associated with a significant increase in HIF-1α expression.

KW - Angiogenesis

KW - Hypoxia

KW - Ovarian cancer

KW - Prostaglandin

UR - http://www.scopus.com/inward/record.url?scp=3543110828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3543110828&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2004.05.010

DO - 10.1016/j.ygyno.2004.05.010

M3 - Article

VL - 94

SP - 422

EP - 426

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -